Selected research
Industry Research
Topical Acne Medication Industry Research Report 2026
Market perspective
The global Topical Acne Medication market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Topical Acne Medication market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Topical Acne Medication market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Topical Acne Medication market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Topical Acne Medication include Teva, Mylan, GlaxoSmithKline, Sun Pharma, Sine Pharma, Mayne Pharma, Lion, HUAPONT and Galderma, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Topical Acne Medication market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Topical Acne Medication.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Topical Acne Medication Market by Company
Teva
Mylan
GlaxoSmithKline
Sun Pharma
Sine Pharma
Mayne Pharma
Lion
HUAPONT
Galderma
Bausch Health
Almirall
Topical Acne Medication Segment by Type
Prescription Medicine
Over-the-counter (OTC) Medicine
Topical Acne Medication Segment by Application
Inflammatory Acne
Non-inflammatory Acne
Topical Acne Medication Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Acne Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Topical Acne Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Acne Medication.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Topical Acne Medication companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Prescription Medicine
- Over-the-counter (OTC) Medicine
Applications
- Inflammatory Acne
- Non-inflammatory Acne
Companies covered
- Teva
- Mylan
- GlaxoSmithKline
- Sun Pharma
- Sine Pharma
- Mayne Pharma
- Lion
- HUAPONT
- Galderma
- Bausch Health
- Almirall
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Topical Acne Medication by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Prescription Medicine
- 2.2.3 Over-the-counter (OTC) Medicine
- 2.3 Topical Acne Medication by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Inflammatory Acne
- 2.3.3 Non-inflammatory Acne
- 2.4 Assumptions and Limitations
3 Topical Acne Medication Breakdown Data by Type
- 3.1 Global Topical Acne Medication Historic Market Size by Type (2021-2026)
- 3.2 Global Topical Acne Medication Forecasted Market Size by Type (2027-2032)
4 Topical Acne Medication Breakdown Data by Application
- 4.1 Global Topical Acne Medication Historic Market Size by Application (2021-2026)
- 4.2 Global Topical Acne Medication Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Topical Acne Medication Market Perspective (2021-2032)
- 5.2 Global Topical Acne Medication Growth Trends by Region
- 5.2.1 Global Topical Acne Medication Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Topical Acne Medication Historic Market Size by Region (2021-2026)
- 5.2.3 Topical Acne Medication Forecasted Market Size by Region (2027-2032)
- 5.3 Topical Acne Medication Market Dynamics
- 5.3.1 Topical Acne Medication Industry Trends
- 5.3.2 Topical Acne Medication Market Drivers
- 5.3.3 Topical Acne Medication Market Challenges
- 5.3.4 Topical Acne Medication Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Topical Acne Medication Players by Revenue
- 6.1.1 Global Top Topical Acne Medication Players by Revenue (2021-2026)
- 6.1.2 Global Topical Acne Medication Revenue Market Share by Players (2021-2026)
- 6.2 Global Topical Acne Medication Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Topical Acne Medication Head Office and Area Served
- 6.4 Global Topical Acne Medication Players, Product Type & Application
- 6.5 Global Topical Acne Medication Manufacturers Established Date
- 6.6 Global Topical Acne Medication Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Topical Acne Medication Market Size (2021-2032)
- 7.2 North America Topical Acne Medication Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Topical Acne Medication Market Size by Country (2021-2026)
- 7.4 North America Topical Acne Medication Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Topical Acne Medication Market Size (2021-2032)
- 8.2 Europe Topical Acne Medication Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Topical Acne Medication Market Size by Country (2021-2026)
- 8.4 Europe Topical Acne Medication Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Topical Acne Medication Market Size (2021-2032)
- 9.2 Asia-Pacific Topical Acne Medication Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Topical Acne Medication Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Topical Acne Medication Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Topical Acne Medication Market Size (2021-2032)
- 10.2 South America Topical Acne Medication Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Topical Acne Medication Market Size by Country (2021-2026)
- 10.4 South America Topical Acne Medication Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Topical Acne Medication Market Size (2021-2032)
- 11.2 Middle East & Africa Topical Acne Medication Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Topical Acne Medication Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Topical Acne Medication Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Teva
- 12.1.1 Teva Company Information
- 12.1.2 Teva Business Overview
- 12.1.3 Teva Revenue in Topical Acne Medication Business (2021-2026)
- 12.1.4 Teva Topical Acne Medication Product Portfolio
- 12.1.5 Teva Recent Developments
- 12.2 Mylan
- 12.2.1 Mylan Company Information
- 12.2.2 Mylan Business Overview
- 12.2.3 Mylan Revenue in Topical Acne Medication Business (2021-2026)
- 12.2.4 Mylan Topical Acne Medication Product Portfolio
- 12.2.5 Mylan Recent Developments
- 12.3 GlaxoSmithKline
- 12.3.1 GlaxoSmithKline Company Information
- 12.3.2 GlaxoSmithKline Business Overview
- 12.3.3 GlaxoSmithKline Revenue in Topical Acne Medication Business (2021-2026)
- 12.3.4 GlaxoSmithKline Topical Acne Medication Product Portfolio
- 12.3.5 GlaxoSmithKline Recent Developments
- 12.4 Sun Pharma
- 12.4.1 Sun Pharma Company Information
- 12.4.2 Sun Pharma Business Overview
- 12.4.3 Sun Pharma Revenue in Topical Acne Medication Business (2021-2026)
- 12.4.4 Sun Pharma Topical Acne Medication Product Portfolio
- 12.4.5 Sun Pharma Recent Developments
- 12.5 Sine Pharma
- 12.5.1 Sine Pharma Company Information
- 12.5.2 Sine Pharma Business Overview
- 12.5.3 Sine Pharma Revenue in Topical Acne Medication Business (2021-2026)
- 12.5.4 Sine Pharma Topical Acne Medication Product Portfolio
- 12.5.5 Sine Pharma Recent Developments
- 12.6 Mayne Pharma
- 12.6.1 Mayne Pharma Company Information
- 12.6.2 Mayne Pharma Business Overview
- 12.6.3 Mayne Pharma Revenue in Topical Acne Medication Business (2021-2026)
- 12.6.4 Mayne Pharma Topical Acne Medication Product Portfolio
- 12.6.5 Mayne Pharma Recent Developments
- 12.7 Lion
- 12.7.1 Lion Company Information
- 12.7.2 Lion Business Overview
- 12.7.3 Lion Revenue in Topical Acne Medication Business (2021-2026)
- 12.7.4 Lion Topical Acne Medication Product Portfolio
- 12.7.5 Lion Recent Developments
- 12.8 HUAPONT
- 12.8.1 HUAPONT Company Information
- 12.8.2 HUAPONT Business Overview
- 12.8.3 HUAPONT Revenue in Topical Acne Medication Business (2021-2026)
- 12.8.4 HUAPONT Topical Acne Medication Product Portfolio
- 12.8.5 HUAPONT Recent Developments
- 12.9 Galderma
- 12.9.1 Galderma Company Information
- 12.9.2 Galderma Business Overview
- 12.9.3 Galderma Revenue in Topical Acne Medication Business (2021-2026)
- 12.9.4 Galderma Topical Acne Medication Product Portfolio
- 12.9.5 Galderma Recent Developments
- 12.10 Bausch Health
- 12.10.1 Bausch Health Company Information
- 12.10.2 Bausch Health Business Overview
- 12.10.3 Bausch Health Revenue in Topical Acne Medication Business (2021-2026)
- 12.10.4 Bausch Health Topical Acne Medication Product Portfolio
- 12.10.5 Bausch Health Recent Developments
- 12.11 Almirall
- 12.11.1 Almirall Company Information
- 12.11.2 Almirall Business Overview
- 12.11.3 Almirall Revenue in Topical Acne Medication Business (2021-2026)
- 12.11.4 Almirall Topical Acne Medication Product Portfolio
- 12.11.5 Almirall Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst